PATENT CLAIM ANALYSIS

Application Number: 16102905
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["424", "093710"]

Abstract:
The technology described herein relates, at least in part, to compositions comprising and methods for isolating and enriching natural IgM-producing phagocytic B (NIMPAB) cells and methods of producing IgM antibodies using such cells, as well as uses of the antibodies produced by the methods for the prevention and treatment of diseases wherein immunotherapy with such natural IgM antibodies and their derivatives can be useful.

Claim (Index 13):
The composition of  claim 11 , wherein the dissociated cell sample is a blood sample.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 96.0
- Lexical Diversity: 1.4
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14346330', '14256777', '13363822', '13773718', '14906663']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7034814250572081
- 35 USC 102 Novelty (BERT): 0.5102660858958625
- Combined Prediction Score: 0.6841598911410737
- Mean Citation Score: 221.341476
- Max Citation Score: 252.30916
- Similarity Product: 162.69374559729573

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test